Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bloomage BioTechnology's Enterprise Value is ¥17,447 Mil.
Bloomage BioTechnology's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥450 Mil. Therefore, Bloomage BioTechnology's EV-to-FCF for today is 38.77.
The historical rank and industry rank for Bloomage BioTechnology's EV-to-FCF or its related term are showing as below:
SHSE:688363'
s EV-to-FCF Range Over the Past 10 Years
Min: -5244.4 Med: -185.01 Max: 488.06
Current: 38.77
During the past 10 years, the highest EV-to-FCF of Bloomage BioTechnology was 488.06. The lowest was -5244.40. And the median was -185.01.
SHSE:688363's EV-to-FCF is ranked worse than 70.26% of 928
companies
in the Chemicals industry
Industry Median: 21.205
vs SHSE:688363: 38.77
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bloomage BioTechnology's PE Ratio (TTM) for today is calculated as:
Bloomage BioTechnology's share price for today is ¥37.55.
Bloomage BioTechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688363 vs LIN, SHW, ECL: EV-to-FCF Comparison
For the Specialty Chemicals subindustry, Bloomage BioTechnology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bloomage BioTechnology EV-to-FCF vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bloomage BioTechnology's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bloomage BioTechnology's EV-to-FCF falls into.
Bloomage BioTechnology's current Enterprise Value is ¥17,447 Mil.
Bloomage BioTechnology's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥450 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology (SHSE:688363) has a EV-to-FCF of 38.77 as of Jul. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bloomage BioTechnology and its competitors. According to the industry distribution chart, Bloomage BioTechnology ranks #652 out of 928 companies in the Chemicals industry, placing it in the top 70.3%.
Is Bloomage BioTechnology's EV-to-FCF too high?
Bloomage BioTechnology's current EV-to-FCF is 38.77. The Chemicals industry median EV-to-FCF is 21.21. Bloomage BioTechnology's value of 38.77 is 82.8% above this industry median. Based on the distribution chart, Bloomage BioTechnology ranks #652 out of 928 companies in the Chemicals industry, which is below the industry midpoint. Overall, Bloomage BioTechnology has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bloomage BioTechnology's EV-to-FCF compare to LIN and SHW?
According to the Chemicals industry distribution chart, Bloomage BioTechnology ranks #652 out of 928 companies for EV-to-FCF. This places Bloomage BioTechnology in the lower half of its industry. The industry median EV-to-FCF is 21.21. Bloomage BioTechnology's value of 38.77 is 82.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Chemicals company?
The median EV-to-FCF among Chemicals companies is 21.21, based on 928 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bloomage BioTechnology's current EV-to-FCF of 38.77 is 82.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bloomage BioTechnology and its competitors. For the Chemicals industry, the median EV-to-FCF is 21.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bloomage BioTechnology's current EV-to-FCF is 38.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bloomage BioTechnology stock overvalued right now?
Based on GuruFocus' analysis, Bloomage BioTechnology (SHSE:688363) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥42.75, compared to a current price of ¥37.55 — trading 12.2% below its estimated fair value. The current EV-to-FCF is 38.77 and 82.8% above the Chemicals industry median of 21.21. Bloomage BioTechnology's overall GF Score™ is 94/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Bloomage BioTechnology (SHSE:688363), the current EV-to-FCF is 38.77 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bloomage BioTechnology (SHSE:688363) Overvalued in 2026?
Based on GuruFocus' analysis, Bloomage BioTechnology stock appears to be undervalued.
The current stock price of ¥37.55 is trading 12.2% below its estimated GF Value™ of ¥42.75.
GuruFocus considers Bloomage BioTechnology to be Modestly Undervalued.
Key valuation signals for SHSE:688363:
EV-to-FCF: 38.77
GF Value™: ¥42.75 vs. price of ¥37.55 (12.2% below fair value)
Industry Position: 82.8% above the Chemicals median (#652 of 928)
No single metric tells the full story. See the SHSE:688363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid or sodium hyaluronic acid. The company's products include raw materials, medical products, functional skincare, and functional foods. Raw materials, mainly hyaluronic acid, are used in pharmaceuticals, medical devices, cosmetics, and food. Medical products span beauty and therapeutic uses, such as viscoelastics, lubricants, fillers, and skin protectors. Skincare items include lotions, creams, and masks, while functional foods feature hyaluronic acid drinks and supplements.
94GF Score
Get the complete analysis for SHSE:688363
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688363 has been successfully added to your 
